Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

TRIAD compositions with neuroprotective efficacy reported by Quebec researchers

Jan. 3, 2001

Inhibitors of PTP1B and their use covered in patent issued to Merck Frosst

Jan. 2, 2001

Novel antiinflammatory agents described by Bayer group

Jan. 2, 2001

Chemokine receptor antagonists in GlaxoSmithKline portfolio

Jan. 2, 2001

Aventis team describes preparation and use of new cell adhesion, migration inhibitors

Jan. 2, 2001

Recent patent covers Lilly's new subtype-selective metabotropic glutamate receptor antagonists

Jan. 2, 2001

New potassium channel modulators synthesized and tested by NeuroSearch

Jan. 2, 2001

Glucagon antagonists jointly claimed by Novo Nordisk and Agouron

Dec. 29, 2000

Compounds active against Plasmodium and cancer cells revealed by ANU

Dec. 29, 2000

PDE4 inhibitors from Merck Frosst

Dec. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...